• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迪米特里奥斯·P·康托扬尼斯纪念我们对毛霉病认识的里程碑式进展

Commemorating the Landmark Advances in Our Understanding of Mucormycosis by Dimitrios P. Kontoyiannis.

作者信息

Walsh Thomas J

机构信息

Center for Innovative Therapeutics and Diagnostics, Richmond, VA 23220, USA.

Departments of Medicine and Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

出版信息

J Fungi (Basel). 2025 Jun 6;11(6):435. doi: 10.3390/jof11060435.

DOI:10.3390/jof11060435
PMID:40558947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193721/
Abstract

Writing with the perspective of a mentor, friend, and colleague, I am elated to contribute to this commemorative issue of the , which is dedicated to the landmark contributions of Dr. Dimitrios P. Kontoyiannis, who has greatly advanced our understanding of the epidemiology, pathogenesis, diagnosis, and treatment of mucormycosis. Through his efforts and leadership, the four pillars in the management of mucormycosis have been made much stronger: early diagnosis, the rapid initiation of antifungal therapy, augmentation of the host's defenses, and surgical intervention.

摘要

以导师、朋友和同事的视角来写这篇文章,我很高兴能为这本纪念专刊撰稿,该专刊致力于纪念迪米特里奥斯·P·康托扬尼斯博士的里程碑式贡献,他极大地推进了我们对毛霉病流行病学、发病机制、诊断和治疗的理解。通过他的努力和领导,毛霉病管理的四大支柱得到了极大加强:早期诊断、迅速开始抗真菌治疗、增强宿主防御能力以及手术干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/12193721/7b023a8bdd88/jof-11-00435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/12193721/8b92c7a040ac/jof-11-00435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/12193721/7b023a8bdd88/jof-11-00435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/12193721/8b92c7a040ac/jof-11-00435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/12193721/7b023a8bdd88/jof-11-00435-g002.jpg

相似文献

1
Commemorating the Landmark Advances in Our Understanding of Mucormycosis by Dimitrios P. Kontoyiannis.迪米特里奥斯·P·康托扬尼斯纪念我们对毛霉病认识的里程碑式进展
J Fungi (Basel). 2025 Jun 6;11(6):435. doi: 10.3390/jof11060435.
2
A fine balancer: commemorating 40 years of the 's revival.一位出色的平衡者:纪念“[具体事物]”复兴40周年。 (你提供的原文中“the 's revival”这里的's指代不明,所以翻译可能不太准确,需根据完整准确的原文来进一步完善)
J Genet. 2025;104.
3
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎(无肌性皮肌炎)的系统评价:特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
4
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.用于预防和治疗健康成人及儿童流感的神经氨酸酶抑制剂。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3.
5
Detection of antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device.使用新开发的侧向流动装置检测支气管肺泡灌洗样本中的抗原。
J Clin Microbiol. 2025 Jun 18:e0022625. doi: 10.1128/jcm.00226-25.
6
Mucormycosis following burn injuries: A systematic review.烧伤后毛霉菌病:一项系统综述。
Burns. 2023 Feb;49(1):15-25. doi: 10.1016/j.burns.2022.05.012. Epub 2022 May 13.
7
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.创伤知情护理服务中使用开放对话模式为心理健康消费者及其家庭网络提供服务:范围综述。
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
8
Utility of Mucorales polymerase chain reaction to diagnose Rhizomucor infections in neutropenic patients.毛霉目聚合酶链反应在诊断中性粒细胞减少患者根霉感染中的应用。
Med Mycol. 2025 Jan 25;63(2). doi: 10.1093/mmy/myaf013.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.用于治疗囊性纤维化的阿他芦醇及类似化合物(针对I类提前终止密码子突变的特定疗法)。
Cochrane Database Syst Rev. 2017 Jan 19;1(1):CD012040. doi: 10.1002/14651858.CD012040.pub2.

本文引用的文献

1
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients.美国移植与细胞治疗学会系列:#8 - 造血细胞移植受者中非曲霉菌霉菌的管理与预防
Transplant Cell Ther. 2025 Apr;31(4):194-223. doi: 10.1016/j.jtct.2025.01.892. Epub 2025 Feb 7.
2
Concordance of Chest Radiography and Chest Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?血液系统恶性肿瘤合并侵袭性毛霉病患者胸部X线与胸部计算机断层扫描结果的一致性:预后意义是什么?
J Fungi (Basel). 2024 Oct 9;10(10):703. doi: 10.3390/jof10100703.
3
Impact of climate change and natural disasters on fungal infections.
气候变化和自然灾害对真菌感染的影响。
Lancet Microbe. 2024 Jun;5(6):e594-e605. doi: 10.1016/S2666-5247(24)00039-9. Epub 2024 Mar 19.
4
Mucormycosis in 2023: an update on pathogenesis and management.2023 年的毛霉菌病:发病机制和治疗的最新进展。
Front Cell Infect Microbiol. 2023 Sep 21;13:1254919. doi: 10.3389/fcimb.2023.1254919. eCollection 2023.
5
Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.年轻 Emberger 综合征伴新发 AML 患者的侵袭性毛霉菌鼻窦炎:GATA2 缺陷侵袭性真菌感染病例报告及文献复习。
Mycoses. 2023 Dec;66(12):1029-1034. doi: 10.1111/myc.13638. Epub 2023 Aug 7.
6
Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors.印度德里 COVID-19 相关毛霉菌病爆发的多模态分析表明临床和环境风险因素的汇聚。
Mycoses. 2023 Jun;66(6):515-526. doi: 10.1111/myc.13578. Epub 2023 Feb 27.
7
Osteoarticular Mycoses.骨与关节真菌病。
Clin Microbiol Rev. 2022 Dec 21;35(4):e0008619. doi: 10.1128/cmr.00086-19. Epub 2022 Nov 30.
8
Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions.检查点抑制剂作为抗真菌免疫疗法:前景、挑战和未解决的问题。
Front Immunol. 2022 Oct 25;13:1018202. doi: 10.3389/fimmu.2022.1018202. eCollection 2022.
9
Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients.分子表型诊断对危重症肺炎患者管理的影响。
Microbiol Spectr. 2022 Oct 26;10(5):e0161622. doi: 10.1128/spectrum.01616-22. Epub 2022 Sep 26.
10
Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis?印度新冠相关毛霉菌病危机中独特的地域性因素是缺失的一环吗?
mBio. 2022 Apr 26;13(2):e0047322. doi: 10.1128/mbio.00473-22. Epub 2022 Mar 31.